News articles

Commission on Narcotic Drugs votes on recommendations for cannabis and cannabis related substances

10 December 2020

On 2 December 2020, Australia voted at the Commission on Narcotic Drugs on six recommendations concerning the scheduling of cannabis and cannabis related substances

Medicinal cannabis permit reform consultation

13 November 2020

The ODC is seeking comments on a review of the structure, design and administrative processes relating to medicinal cannabis related permits

Webinar: Kava Pilot Phase 2 design (easing the restrictions on the commercial importation of kava)

10 November 2020

Webinar presentation has been added

Commencement of fees and charges for cannabis-related manufacture

2 November 2020

Cost recovery arrangements for cannabis-related manufacture licences and permits commenced on 1 November 2020.

Introduction of fees and charges for cannabis-related manufacture

6 October 2020

From 1 November 2020, subject to formal approval from the Federal Executive Council, cost recovery arrangements will be extended to cannabis-related manufacture licences and permits under the Medicinal Cannabis Scheme.

Reforms to Medicinal Cannabis Scheme Fees and Charges

27 July 2020

Changes to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020

Australian Government proposes strengthening its stance against e-cigarettes containing vaporiser nicotine

29 June 2020

From 1 January 2021, proposed regulations would prohibit the importation of e-cigarettes containing vaporiser nicotine.

Consultation: Medicinal Cannabis Cost Recovery Framework

13 March 2020

The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework. Closing date: 20 March 2020

Single Licence Model Consultation: Closing date for submissions

22 January 2020

Submissions in response to the Office of Drug Control's (ODCs) Consultation on Single Licence Model close COB Monday 3 Feb

Implementation of the Review of the Narcotic Drugs Act 1967 (Cth)

17 December 2019

The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967